Regorafenib
Bayer
[]
 breaking news from asco gi:
integrate iia clinical trial demonstrates improved survival with new treatment for advanced gastro-oesophageal cancer patients. #gi23 read the full story: congratulations to everyone involved! 
We raise funds for clinical research which improves gastro-intestinal cancer treatment and conduct research as the Australasian Gastro-Intestinal Trials Group.